Opportunity ID: 282696

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-16-025
Funding Opportunity Title: Integrating Supersaturation-precipitation Mechanisms in Mechanistic Oral Absorption Models for Predicting In- vivo Performance of Associated Formulations (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 01, 2016
Last Updated Date:
Original Closing Date for Applications: Jun 03, 2016
Current Closing Date for Applications: Jun 03, 2016
Archive Date: Jul 03, 2016
Estimated Total Program Funding: $500,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Public housing authorities/Indian housing authorities
State governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
City or township governments
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
County governments
Special district governments
Small businesses
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: The objectives of this project are to: 1) integrate in vivo supersaturation-precipitation mechanisms into mechanism-based oral absorption models for poorly water-soluble drugs formulated into supersaturable systems, and 2) to establish a mechanism-based in vitro-in vivo correlation (IVIVC) for these drug products.
Link to Additional Information: Full Announcement of RFA-FD-16-021
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Bozoian

Grants Management Specialist

Phone 2404027623
Email:eric.bozoian@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Eric Bozoian
Grants Management Specialist
Phone 2404027623
Email: eric.bozoian@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00222284 Apr 04, 2016 Jun 03, 2016 View

Package 1

Mandatory forms

282696 RR_SF424_2_0-2.0.pdf

282696 PHS398_CoverPageSupplement_3_0-3.0.pdf

282696 RR_OtherProjectInfo_1_3-1.3.pdf

282696 PerformanceSite_2_0-2.0.pdf

282696 RR_KeyPersonExpanded_2_0-2.0.pdf

282696 RR_Budget_1_3-1.3.pdf

282696 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282696 RR_SubawardBudget30_1_3-1.3.pdf

282696 PHS_Inclusion_Enrollment_Report-1.0.pdf

282696 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T11:39:41-05:00

Share This Post, Choose Your Platform!

About the Author: